Urolog. pro Praxi, 2009; 10(2): 69-71

Plastic induration of penis - local therapy with verapamil

MUDr. Libor Zámečník FEBU1, Mgr. Marie Korousová2
1 Urologická klinika 1. LF UK a VFN Praha
2 Nemocniční lékárna VFN Praha

Induratio penis plastica or Peyronie‘s disease is characterized by the presence of fibrous plaques in the tunica albuginea of the penis. It is

a connective tissue disease primarily affecting the tunica albuginea. The plaques are mainly composed of collagen and may significantly

alter the anatomy and function of the penis. Treatment is difficult; medication therapy should always be initiated first. If oral medication

fails, treatment with local injection applied directly into the plaque can be used. The author reviews the literature data and his own

results of treatment with verapamil administered locally in 17 patients with this disease.

Keywords: induratio penis plastica, Peyronie‘s disease, verapamil.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zámečník L, Korousová M. Plastic induration of penis - local therapy with verapamil. Urol. praxi. 2009;10(2):69-71.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amarenco G, Casanova JM. Lesion of the dorsal nerve of the penis in Peyronie's disease. Prog Urol 1991; 1: 906-910. Go to PubMed...
    2. Kubíček V. Současný stav léčby Peyronieho choroby. Urolog. pro Praxi 2003; 3: 11-13.
    3. Kisselgoff D, Lebensart PD, Shenfeld OZ. Penile compartment syndrome: a possible explanation for penile pain in Peyronie disease shown by penile sonography. J Ultrasound Med 2007; 26: 657-660. Go to original source... Go to PubMed...
    4. Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, Engelmann U. Epidemiology of Peyronie's disease. Int J Impot Res 2002; 14: 379-383. Go to original source... Go to PubMed...
    5. Levine LA, Estrada CR, Storm DW, Matkov TG. Peyronie disease in younger men: characteristics and treatment results. J Androl 2003; 24: 27-32. Go to PubMed...
    6. Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction. Int J Impot Res 2007; 19: 213-217. Go to original source... Go to PubMed...
    7. Kendirci M, Trost L, Sikka SC, Hellstrom WJ. Diabetes mellitus is associated with severe Peyronie's disease. BJU Int 2007; 99: 383-386. Go to original source... Go to PubMed...
    8. Hauck EW, Hauptmann A, Haag SM, Weidner W. New Insights into the Etiological Pathogenesis of Peyronie's Disease. Akt Urol 2003; 34: 387-391.
    9. Kadioglu A, Tefekli A, Erol H, Cayan S, Kandirali E. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease. Int J Impot Res 2000; 12: 263-267. Go to original source... Go to PubMed...
    10. Trost LW, Gur S, Hellstrom WJ. Pharmacological Management of Peyronie's Disease. Drugs 2007; 67: 527-545. Go to original source... Go to PubMed...
    11. Bodner H, Howard A H, Kaplan J H. Peyronie's disease: Cortisone-hyaluronidase-hydrocortisone therapy. J Urol 1954; 72: 400-403. Go to original source... Go to PubMed...
    12. Gelbard M, Walsh R, Kaufman JJ. Clostridial collagenase and Peyronie disease. Urology 1980; 15: 536. Go to original source... Go to PubMed...
    13. Gelbard MK, James K, Riach P. Collagenase versus placebo in the treatment of Peyronie´s disease: a double-blind study. J Urol 1993; 149: 56-58. Go to original source... Go to PubMed...
    14. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 1991; 25: 89-94. Go to original source... Go to PubMed...
    15. Zámečník L, Soukup V, Stolz J, Hanuš T. Local application of interferon-alpha 2B in treatment of Peyronie´s disease: our experience in 19 patients. Asian J Androl 2006; 8: 63.
    16. Zámečník L, Stolz J, Soukup V, Hanuš T. Využití lokální aplikace Interferonu-alfa 2b v léčbě induratio penis plastica. Čes Urol 2004; 8: 11-12.
    17. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol 1994; 151: 1522-1524. Go to original source... Go to PubMed...
    18. Hrabec M, Študent V. Our experience in local application of the verapamil in patients with induratio plastica penis. Eur Androl Suppl 2007; 1: 50.
    19. Zámečník L. Local application of verapamil in the treatment of Peyronie´s disease: our experience in 12 patients. Eur Androl Suppl 2007; 1: 50.
    20. Fitch WP, 3rd, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease-a placebo-controlled pilot study. J Sex Med 2007; 4: 477-484. Go to original source... Go to PubMed...
    21. Shindel AW, Bullock TL, Brandes S. Urologist practice patterns in the management of Peyronie's disease: a nationwide survey. J Sex Med 2008; 5: 954-964. Go to original source... Go to PubMed...
    22. Riedl CR, Plas E, Engelhardt P, Daha K, Pfluger H. Iontophoresis for treatment of Peyronie's disease. J Urol 2000; 163: 95-99. Go to original source... Go to PubMed...
    23. Russell S, Steers W, McVary KT. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. Eur Urol 2007; 51: 640-647. Go to original source... Go to PubMed...
    24. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 1997; 158: 1395-1399. Go to original source... Go to PubMed...
    25. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 2002; 168: 621-625; discussion 625-626. Go to original source... Go to PubMed...
    26. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 1998; 51: 620-626. Go to original source... Go to PubMed...
    27. Cavallini G, Modenini F, Vitali G. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease. Urology 2007; 69: 950-954. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.